The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2020

Filed:

Jul. 15, 2016
Applicant:

Dana-farber Cancer Institute, Inc., Boston, MA (US);

Inventors:

Kai W. Wucherpfennig, Brookline, MA (US);

Bettina Franz, Orem, UT (US);

Kenneth F. May, Jr., Bozeman, MT (US);

Glenn Dranoff, Sudbury, MA (US);

F. Stephen Hodi, Framingham, MA (US);

Christopher Harvey, Boston, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 16/06 (2006.01); C07K 16/12 (2006.01); C07K 16/22 (2006.01); A61K 45/06 (2006.01); A61K 31/365 (2006.01); A61K 31/325 (2006.01); A61K 31/16 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2833 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); C07K 16/06 (2013.01); C07K 16/1282 (2013.01); C07K 16/22 (2013.01); A61K 31/16 (2013.01); A61K 31/325 (2013.01); A61K 31/365 (2013.01); A61K 39/39558 (2013.01); C07K 2317/10 (2013.01); C07K 2317/21 (2013.01); C07K 2317/565 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The present disclosure provides, in part, compositions comprising peptides that immunospecifically bind to a defined binding partner, such as MHC class I polypeptide-related sequence A (MICA), or an epitope thereon. In some embodiments, the peptides comprise one or more complementarity determining regions relating to the complementarity regions shown in Table 1. The disclosure also provides methods of treating cancer in a subject using the compositions disclosed herein, and methods of isolating human antibodies from cancer patients following immunotherapy.


Find Patent Forward Citations

Loading…